Shares of Oculus Innovative Sciences, Inc. (OCLS) are rallying, up nearly nearly 28 percent on Monday morning after it was granted FDA 510(k) clearance for Alevicyn SG Antipruritic Gel. Shares of Tobira Therapeutics, Inc. (TBRA) are higher by nearly 23% to $21.90 in midday trading on Monday after the company announced completion of recruitment for […] View the full post at: Trader’s Buzz: Oculus Innovative Sciences (OCLS), Tobira Therapeutics (TBRA), Pozen Inc. (POZN), MannKind Corp. (MNKD) Related posts: FDIC’s Bair Says Getting Innovative in Bank Deals Gilead Sciences Announces Large Buyback Gilead Sciences is in Great Health